Page last updated: 2024-08-22

methylprednisolone hemisuccinate and T-Cell Lymphoma

methylprednisolone hemisuccinate has been researched along with T-Cell Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, WZ; Zhang, QY; Zhao, S1
Avnir, Y; Barenholz, Y; Gabizon, A; Kizelsztein, P; Sigal, A; Tulchinsky, D; Turjeman, K; Tzemach, D1

Other Studies

2 other study(ies) available for methylprednisolone hemisuccinate and T-Cell Lymphoma

ArticleYear
[Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction

2010
Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Animals; Capsules; Chemical Phenomena; Chemistry, Pharmaceutical; Encephalomyelitis, Autoimmune, Experimental; Female; Glucocorticoids; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia; Liposomes; Lymphoma, T-Cell; Methylprednisolone Hemisuccinate; Mice; Multiple Sclerosis; Myelin Proteolipid Protein; Nanostructures; Solubility; Water

2011